Synopsys, Inc. $SNPS Shares Sold by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp trimmed its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 7.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 30,384 shares of the semiconductor company’s stock after selling 2,552 shares during the quarter. UNIVEST FINANCIAL Corp’s holdings in Synopsys were worth $13,215,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in SNPS. Machina Capital S.A.S. lifted its stake in Synopsys by 18.8% in the third quarter. Machina Capital S.A.S. now owns 5,887 shares of the semiconductor company’s stock valued at $2,560,000 after buying an additional 933 shares during the last quarter. Riverbridge Partners LLC boosted its holdings in shares of Synopsys by 23.2% during the third quarter. Riverbridge Partners LLC now owns 69,586 shares of the semiconductor company’s stock valued at $30,266,000 after acquiring an additional 13,105 shares during the period. Bahl & Gaynor LLC bought a new position in shares of Synopsys during the third quarter worth about $365,000. New York Life Investment Management LLC grew its position in shares of Synopsys by 3.2% during the third quarter. New York Life Investment Management LLC now owns 32,258 shares of the semiconductor company’s stock worth $14,030,000 after acquiring an additional 986 shares during the last quarter. Finally, Kinsale Capital Group Inc. grew its position in shares of Synopsys by 26.7% during the third quarter. Kinsale Capital Group Inc. now owns 29,484 shares of the semiconductor company’s stock worth $12,824,000 after acquiring an additional 6,214 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Analysts Set New Price Targets

SNPS has been the topic of several recent research reports. JPMorgan Chase & Co. cut their price objective on shares of Synopsys from $650.00 to $600.00 in a research report on Thursday, August 27th. Rosenblatt Securities upped their target price on shares of Synopsys from $575.00 to $620.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Weiss Ratings lowered shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. BNP Paribas Exane raised their price target on shares of Synopsys from $420.00 to $475.00 and gave the company a “neutral” rating in a research note on Thursday, October 1st. Finally, Roth Capital upgraded Synopsys to a “buy” rating in a research report on Friday, September 25th. One analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and an average price target of $575.00.

Synopsys Price Performance

NASDAQ SNPS opened at $462.12 on Thursday. Synopsys, Inc. has a 12 month low of $362.55 and a 12 month high of $539.48. The firm has a market capitalization of $88.56 billion, a PE ratio of 46.74, a P/E/G ratio of 1.46 and a beta of 1.18. The company’s 50 day simple moving average is $443.45 and its 200 day simple moving average is $441.55. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The firm had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the prior year, the firm posted $3.39 earnings per share. The firm’s revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, equities research analysts forecast that Synopsys, Inc. will post 11.01 EPS for the current fiscal year.

Synopsys declared that its board has authorized a stock buyback plan on Monday, October 5th that allows the company to repurchase $1 billion in outstanding shares. This buyback authorization allows the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its stock is undervalued.

Insider Transactions at Synopsys

In related news, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the completion of the transaction, the chief financial officer owned 22,717 shares of the company’s stock, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Aart de Geus sold 25,000 shares of Synopsys stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the transaction, the insider directly owned 120,421 shares in the company, valued at approximately $53,197,180.96. The trade was a 17.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 117,163 shares of company stock worth $51,366,457. Corporate insiders own 0.56% of the company’s stock.

About Synopsys

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.